Asli Kucukosmanoglu
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.
Journal: Neuro-oncology advances
Published: July 17, 2023
Review: A Roadmap to Use Nonstructured Data to Discover Multitarget Cancer Therapies.
Journal: JCO clinical cancer informatics
Published: April 28, 2023
A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 18, 2023
Oncogenic composite mutations can be predicted by co-mutations and their chromosomal location.
Journal: Molecular oncology
Published: December 14, 2022
The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 16, 2019
WINDOW consortium: A path towards increased therapy efficacy against glioblastoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: July 17, 2018
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.
Journal: Cancer research
Published: July 12, 2018
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells.
Journal: eLife
Published: May 01, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026